Health, Medical & Pharma News - Updated Daily page 14

Prenatal SSRI Exposure Linked to Functional Constipation in Offspring

Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) is associated with an increased risk of functional constipation developing in offspring, ac

SABCS: Active Monitoring Noninferior to Guideline Care for Ductal Carcinoma in Situ

For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) that involves surgery with or withou

U.S. Adult Obesity Rate Fell in 2023, as Use of GLP-1 Meds Rose

the first decline in a decade, according to Rader s team. The percentage of Americans who were obese also declined slightly that year. Declines were steepest in

Breast, Ovary Removal Can Lengthen Lives of Women With Breast Cancer Genes

It s a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-risk genes may be able to prevent their cance

'Watch and Wait' May Equal Active Treatment for Early DCIS Breast Cancers, Studies Find

A watch-and-wait strategy might be the best option for some women with early-stage, low-risk breast cancer.According to two new studies presented Thursday at th

Blood Test Might Alert Doctors to Problem Drinking

possibly because they either minimized or couldn t accurately remember how much alcohol they d consumed, researchers said.This was the largest examination yet o

Newer Drug Could Be Advance Against Tough-to-Treat Breast Cancers

An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast cancer, a new clinical trial shows.Th

Eat Less Meat, More Beans & Lentils for Protein, New USDA Guidelines Say

Beans, peas and lentils take center stage in newly proposed changes to dietary guidelines for Americans.In a report released this week by an advisory committee

Pilatus Biosciences Inc. Receives Orphan Drug Designation from FDA for PLT012 in Treatment of Liver and Intrahepatic Bile Duct Cancer

Pilatus Biosciences Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its leading molecu

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial

Repare Therapeutics Inc. ( Repare or the Company ) (Nasdaq RPTX), a leading clinical-stage precision oncology company, today reported positive data from its MYT

Pharmaceutical News and Articles